Virtus Investment Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $447K | Buy |
852
+366
| +75% | +$192K | 0.15% | 198 |
|
|
2025
Q1 | $308K | Buy |
+486
| New | +$308K | 0.08% | 239 |
|
|
2023
Q2 | – | Sell |
-601
| Closed | -$494K | – | 293 |
|
|
2023
Q1 | $494K | Hold |
601
| – | – | 0.35% | 91 |
|
|
2022
Q4 | $434K | Hold |
601
| – | – | 0.29% | 110 |
|
|
2022
Q3 | $414K | Buy |
+601
| New | +$414K | 0.19% | 110 |
|
|
2018
Q1 | – | Sell |
-328
| Closed | -$123K | – | 351 |
|
|
2017
Q4 | $123K | Sell |
328
-6
| -2% | -$2.25K | 0.01% | 456 |
|
|
2017
Q3 | $149K | Sell |
334
-39
| -10% | -$17.4K | 0.02% | 441 |
|
|
2017
Q2 | $183K | Sell |
373
-51
| -12% | -$25K | 0.02% | 430 |
|
|
2017
Q1 | $164K | Buy |
+424
| New | +$164K | 0.01% | 424 |
|
|
2016
Q4 | – | Sell |
-1,608
| Closed | -$646K | – | 520 |
|
|
2016
Q3 | $646K | Buy |
+1,608
| New | +$646K | 0.04% | 325 |
|